Disc Medicine, Inc. Share Price & Technical Analysis
IRON · $66.82 (-0.46%)
Healthcare / Biotechnology
$66.82
-0.46%
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associa…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
1% return in May, 10% avg return in past 3 year May month.
-11% return in 2026, 97% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | -13% | -1% | 3% | 1% | – | – | – | – | – | – | – | -11% |
| 25 | -13% | 2% | -12% | 0% | -5% | 13% | 12% | 1% | 11% | 30% | 7% | -15% | 33% |
| 24 | 15% | 4% | -9% | 5% | 22% | 31% | -3% | 17% | -3% | -9% | 41% | 0% | 111% |
| 23 | 23% | 20% | -16% | 54% | 12% | 20% | 16% | 7% | -11% | -2% | 21% | 4% | 147% |
| 22 | -33% | -32% | 7% | 9% | -14% | 33% | -11% | 0% | 8% | 5% | -4% | -61% | -93% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.63B
P/E ratio
—
52W high
$99.50
52W low
$40.00
Volume
3,42,496
Beta
2.14
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Disc Medicine, Inc. share price today?
- Disc Medicine, Inc. (IRON) last traded around $66.82 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IRON have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IRON. Download the app for real-time alerts.
- How can I analyze Disc Medicine, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.